SCHEMBL18566117

SCHEMBL18566117

Cn1c2ccccc2c2ccc3c4ccccc4p(-c4ccccc4)c3c21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.46
▸ FTO Q9C0B1 1/20 0.46
▸ GPR3 P46089 1/20 0.44
▸ KDM4E B2RXH2 7/20 0.41
▸ MAPT P10636 3/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ IDO1 P14902 1/20 0.41
▸ HPGD P15428 5/20 0.36
▸ HSD17B10 Q99714 4/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ LMNA P02545 2/20 0.36
▸ KIF11 P52732 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ BCHE P06276 3/20 0.35
▸ ACHE P22303 3/20 0.35
▸ LIMK1 P53667 1/20 0.34
▸ GABRP O00591 1/20 0.34
▸ GABRD O14764 1/20 0.34
▸ GABRA1 P14867 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18566167 0.85 ALKBH5 (0.41) ALKBH5FTOGPR3KDM4EMAPT
SCHEMBL18566166 0.85 ALKBH5 (0.32) ALKBH5FTOKDM4EMAPTHPGD
SCHEMBL18566162 0.83 ALKBH5 (0.39) ALKBH5FTOGPR3KDM4EMAPT
SCHEMBL18566130 0.82 ALKBH5 (0.44) ALKBH5FTOGPR3KDM4EMAPT
SCHEMBL18566165 0.81 KDM4E (0.33) KDM4EMAPTHPGDHSD17B10RAB9A
SCHEMBL18566116 0.81 NQO2 (0.44) GPR3KDM4EMAPTHPGDHSD17B10
SCHEMBL18566187 0.79 KDM4E (0.46) ALKBH5FTOGPR3KDM4EMAPT
SCHEMBL18566172 0.79 KDM4E (0.46) ALKBH5FTOGPR3KDM4EMAPT
SCHEMBL18565386 0.79 ALKBH5 (0.41) ALKBH5FTOGPR3KDM4EMAPT
SCHEMBL18565394 0.75 RXRA (0.50) GPR3KDM4EMAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 ALKBH5 265/4885FTO 202/4885GPR3 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback